期刊文献+

HPLC法测定奈韦拉平的血药浓度 被引量:1

Determination of Nevirapine in Human Plasma by High Performance Liquid Chromatography
下载PDF
导出
摘要 目的:建立高效液相色谱法测定奈韦拉平血药浓度的方法。方法:采用Hypersil C18柱(150min×4.6mm,0.5μm);流动相:乙腈:0.01mol/L磷酸二氢钠(含0.01mol/L三乙胺,磷酸调pH至5.O)。18。82;流量:1.0mL/min;检测波长:240nm。结果:线性范围0.1~5.0mg/L(r=0.9996);最低检测浓度为0.1mg/L;日内、日间相对标准差(RSD%)均小于10%;低、中、高三个浓度的提取回收率分别为99.98%、99.41%和100.53%。结论:该法简便、快速、准确,专属性高,适用于奈韦拉平药动学和生物等效性研究。 Objective:To establish a method for the determination of nevirapine in human plasma using HPLC. Methods: The analytic column was Hypersil C18 column(150 mm×4. 6 mm,0. 5μm). The mobile phase was acetonitrile-0.01 mol/L NaH2PO4 (including 0.01mol/L acetamide and adjust pH to 5.0 with H3PO4). The flow rate was 1.0 mL/min. The detection wavelength was 240 nm. Results:Nevirapine concentration presented a good linear range of 0.1-5.0 mg/L(r =0. 9996)had the limit of quantitation was 0.1 mg/L. The relative standard deviations of withinday and between-days were less than 10%. The recovery was between 99.41% and 100.53%. Conclusion: The method is rapid, simple and accurate for the determination of nevirapine in human plasma. It is suitable for the pharmacokinetics and bioavailability study of nevirapine.
作者 周细根 陈汇
出处 《实用临床医学(江西)》 CAS 2006年第9期16-17,19,共3页 Practical Clinical Medicine
关键词 高效液相色谱法 奈韦拉平 血药浓度 HPLC nevirapine drug concentration in plasma
  • 相关文献

参考文献10

  • 1TEBAS P,YARASHESKIK,HENRY K,et al.Evaluation of the Virological and Metabolic Effects of Switching Protease Inhibitor Combination Antiretroviral Therapy to Nevirapine-based Therapy for the Treatment of HIV Infection[J].AIDS Res Hum Retroviruses,2004,20:589-594. 被引量:1
  • 2MANOSUTHI W,SUNGKANUPARPH S,VIBHAGOOL A,et al.Nevirapine-versus Efavirenz-based Highly Active Antiretroviral Therapy Regimens in Antiretroviral-naīve patients with advanced HIV infection[J].HIV Med,2004; 5:105-109. 被引量:1
  • 3LAURITOTL,SANTAGADA V,CALIENDO G,et al.Nevirapine Quantification in Human Plasma by High-performance Liquid Chromatography Coupled to Electrospray Tandem Mass Spectrometry.Application to Bioequivalence Study[J].J Mass Spectrom,2002,37:434-441. 被引量:1
  • 4LOPEZ R M,POU L,GOMEZ M R,et al.Simple and Rapid Determination of Nevirapine in Human Serum by Reversedphase High-performance Liquid Chromatography[J].J Chromatogr B,2001,751:371-376. 被引量:1
  • 5FAN B,STEWART J T.Determination of Zidovudine/lamivudine/nevirapine in Human Plasma Using Lon-pair HPLC[J].J Pharm Biomed Anal,2002,28:903-908. 被引量:1
  • 6COLOMBO S,BEGUIN A,MARZOLINI C,et al.Determination of the Novel Non-peptidic HIV-protease Inhibitor Tipranavir by HPLC-UV after Solid-phase Extraction[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,17; 832(1):138-143. 被引量:1
  • 7NOTARI S,BOCEDI A,LPPOLITO G,et al.Simultaneous Determination of 16 Anti-HIV Drugs in Human Plasma by High-performance Liquid Chromatography[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,831 (1-2):258-266. 被引量:1
  • 8CHEESEMAN S H,HATTOX S E,MCLAUGHLIN M M,et al.Pharmacokinetics of Nevirapine:Initial Single-rising-dose Study in Humans[J].Antimicrob Agents Chemother,1993,37(2) ; 178-182. 被引量:1
  • 9GKENGIN D,YAMAZHAN T.Hepatic Adverse Events During Highly Active Antiretroviral Therapy Containing Nevirapine:a Case Report[J].Ann Clin Microbiol Antimicrob,2002:1:1. 被引量:1
  • 10MANOSUTHI W,CHUMPATHAT N,CHAOVAVANICH A,et al.Safety and Tolerability of Nevirapine-based Antiretroviral Therapy in HIV-infected Patients Receiving Fluconazole for Cryptococcal Prophylaxis:a Case-control Study[J].BMC Infect Dis,2005,5:67. 被引量:1

同被引文献14

  • 1吴翠敏,邱彬,卢春华,吕爱星.荧光淬灭法分析奈韦拉平含量[J].福建医科大学学报,2006,40(5):523-525. 被引量:2
  • 2YAOYa-min(姚亚敏) SUNJian-jun(孙建军).LC-MS/MS method for simultaneous quantification of nevirapine lamivudine stavudine zidovudine efavirenz in human plasma(LC-MS/MS法同时测定奈韦拉平、拉米夫定、司他夫定、齐多夫定和依非韦伦的血浆浓度)[J].公共卫生与临京医学,5(3):170-170. 被引量:1
  • 3Lois S.Rowland,Thomas R,Mac Gregor.Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry.J Chromatogr B,2007,9(8):252. 被引量:1
  • 4Hiren NM,Pranav S,Arvind GJ,et al.Development and validation of a rapid liquid chromatography tandem mass spectrometry method to quantify nevirapine in human plasma and its application to bioequivalence study in healthy human subjects.Anal Lett,2007,40(6):1147. 被引量:1
  • 5Lemmer P,Schneider S,Schuman M,et al. Determination of nevirapine and efavirenz in plasma using GC/MS in selected ion monitoring mode.Ther Drug Monit,2005,(27):521. 被引量:1
  • 6Stefania Notari,Carmine Mancone,Tonino Alonzi.Determination of abacavir,amprenavir,didanosine,efavirenz,nevirapine,and stavudine concentration in human plasma by MALDI-TOF/TOF.J Chromatogr B,2008,863(6):249. 被引量:1
  • 7Elisabete A Pereira,Gustavo A Micke,Marina FM.Tavares.Determination of antiretroviral agents in human serum by capillary electrophoresis.J Chromatogr A, 2005,1091(7):169. 被引量:1
  • 8Palaniappan Mohanraj,Deb Kumar Sarkara and Karunakaran.Simple and rapid RP-HPLC method for the estimation of nevirapine in bulk and pharmaceutical dosage forms.E-J Chem,2008,5(S2):1081. 被引量:1
  • 9Prasada Rao CH,Channabasavaraj KP.Development and validation of RP-HPLC method for the estimation of nevirapine in bulk drug and tablets.J Pharm Sci Res,2009,1(2):78. 被引量:1
  • 10Kaul N,Agrawal H,Paradkar AR,et al.HPTLC method for determination of nevirapine in pharmaceutical dosage form.Talanta,2004,64(5):843. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部